Principal component analysis of breast DCE‐MRI adjusted with a model‐based method

To investigate a fast, objective, and standardized method for analyzing breast dynamic contrast‐enhanced magnetic resonance imaging (DCE‐MRI) applying principal component analysis (PCA) adjusted with a model‐based method.

[1]  Elizabeth A Morris,et al.  Diagnostic breast MR imaging: current status and future directions. , 2010, Magnetic resonance imaging clinics of North America.

[2]  L. Turnbull Dynamic contrast‐enhanced MRI in the diagnosis and management of breast cancer , 2009, NMR in biomedicine.

[3]  Erez Eyal,et al.  Model‐based and model‐free parametric analysis of breast dynamic‐contrast‐enhanced MRI , 2009, NMR in biomedicine.

[4]  P. Tan,et al.  Independent component analysis of dynamic contrast‐enhanced magnetic resonance images of breast carcinoma: A feasibility study , 2008, Journal of magnetic resonance imaging : JMRI.

[5]  C. Boetes,et al.  Breast MRI: guidelines from the European Society of Breast Imaging , 2008, European Radiology.

[6]  Anne L. Martel,et al.  Removing undersampling artifacts in DCE‐MRI studies using independent components analysis , 2008, Magnetic resonance in medicine.

[7]  Hiroyuki Abe,et al.  Differentiation between benign and malignant breast lesions detected by bilateral dynamic contrast‐enhanced MRI: A sensitivity and specificity study , 2008, Magnetic resonance in medicine.

[8]  E. Eyal,et al.  Combination of model-free and model-based analysis of dynamic contrast enhanced MRI for breast cancer diagnosis , 2008, SPIE Medical Imaging.

[9]  C. Kuhl The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. , 2007, Radiology.

[10]  Lorenzo L. Pesce,et al.  Reliable and computationally efficient maximum-likelihood estimation of "proper" binormal ROC curves. , 2007, Academic radiology.

[11]  Lina Arbash Meinel,et al.  Breast MRI lesion classification: Improved performance of human readers with a backpropagation neural network computer‐aided diagnosis (CAD) system , 2007, Journal of magnetic resonance imaging : JMRI.

[12]  Anne L. Martel A Fast Method of Generating Pharmacokinetic Maps from Dynamic Contrast-Enhanced Images of the Breast , 2006, MICCAI.

[13]  M. Giger,et al.  Automatic identification and classification of characteristic kinetic curves of breast lesions on DCE-MRI. , 2006, Medical physics.

[14]  P J Drew,et al.  Differentiation of benign from malignant breast disease associated with screening detected microcalcifications using dynamic contrast enhanced magnetic resonance imaging. , 2006, Breast.

[15]  Edna Schechtman,et al.  Magnetic resonance imaging reveals functional diversity of the vasculature in benign and malignant breast lesions , 2005, Cancer.

[16]  Mitchell D Schnall,et al.  Imaging in breast cancer: Magnetic resonance imaging , 2005, Breast Cancer Research.

[17]  D. Collins,et al.  Dynamic magnetic resonance imaging of tumor perfusion , 2004, IEEE Engineering in Medicine and Biology Magazine.

[18]  Axel Saalbach,et al.  Image fusion for dynamic contrast enhanced magnetic resonance imaging , 2004, Biomedical engineering online.

[19]  R. Lucht,et al.  Microcirculation and microvasculature in breast tumors: Pharmacokinetic analysis of dynamic MR image series , 2004, Magnetic resonance in medicine.

[20]  Peter Aspelin,et al.  Application of artificial neural networks to the analysis of dynamic MR imaging features of the breast , 2004, European Radiology.

[21]  David J Collins,et al.  Dynamic magnetic resonance imaging of tumor perfusion. Approaches and biomedical challenges. , 2004, IEEE engineering in medicine and biology magazine : the quarterly magazine of the Engineering in Medicine & Biology Society.

[22]  L. Turnbull,et al.  Textural analysis of contrast‐enhanced MR images of the breast , 2003, Magnetic resonance in medicine.

[23]  S. Yoo,et al.  Independent Component Analysis for the Examination of Dynamic Contrast-Enhanced Breast Magnetic Resonance Imaging Data: Preliminary Study , 2002, Investigative radiology.

[24]  Frederick Kelcz,et al.  Clinical testing of high-spatial-resolution parametric contrast-enhanced MR imaging of the breast. , 2002, AJR. American journal of roentgenology.

[25]  Edna Furman-Haran,et al.  Parametric analysis of breast MRI. , 2002, Journal of computer assisted tomography.

[26]  M D Schnall,et al.  MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. , 2001, Radiology.

[27]  G Brix,et al.  Classification of signal-time curves from dynamic MR mammography by neural networks. , 2001, Magnetic resonance imaging.

[28]  G Brix,et al.  Pathophysiologic basis of contrast enhancement in breast tumors , 1999, Journal of magnetic resonance imaging : JMRI.

[29]  M. Knopp,et al.  Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.

[30]  C. Kuhl,et al.  Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? , 1999, Radiology.

[31]  J. Gomori,et al.  Breast fibroadenoma: mapping of pathophysiologic features with three-time-point, contrast-enhanced MR imaging--pilot study. , 1999, Radiology.

[32]  P J Drew,et al.  Dynamic MR imaging of the breast combined with analysis of contrast agent kinetics in the differentiation of primary breast tumours. , 1997, Clinical radiology.

[33]  Scott Fields,et al.  Mapping pathophysiological features of breast tumors by MRI at high spatial resolution , 1997, Nature Medicine.

[34]  Kurt Hornik,et al.  Learning in linear neural networks: a survey , 1995, IEEE Trans. Neural Networks.

[35]  P S Tofts,et al.  Quantitative Analysis of Dynamic Gd‐DTPA Enhancement in Breast Tumors Using a Permeability Model , 1995, Magnetic resonance in medicine.

[36]  I. Gribbestad,et al.  Contrast-enhanced magnetic resonance imaging of the breast. , 1992, Acta oncologica.

[37]  P. Tofts,et al.  Measurement of the blood‐brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts , 1991, Magnetic resonance in medicine.

[38]  L R Schad,et al.  Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. , 1991, Journal of computer assisted tomography.

[39]  O Henriksen,et al.  Quantitation of blood‐brain barrier defect by magnetic resonance imaging and gadolinium‐DTPA in patients with multiple sclerosis and brain tumors , 1990, Magnetic resonance in medicine.